177 related articles for article (PubMed ID: 37955612)
21. Gene Expression Profiling Prognostication of Posterior Uveal Melanoma: Does Size Matter?
Binkley EM; Bena JF; Davanzo JM; Hinz C; Boldt HC; Singh AD
Ophthalmol Retina; 2020 Jun; 4(6):620-629. PubMed ID: 32081600
[TBL] [Abstract][Full Text] [Related]
22. Proteomic insight into the pathogenesis of CAPN5-vitreoretinopathy.
Velez G; Yang J; Li AS; Tsang SH; Bassuk AG; Mahajan VB
Sci Rep; 2019 May; 9(1):7608. PubMed ID: 31110225
[TBL] [Abstract][Full Text] [Related]
23. Independent Prognostic Significance of Gene Expression Profile Class and Largest Basal Diameter of Posterior Uveal Melanomas.
Corrêa ZM; Augsburger JJ
Am J Ophthalmol; 2016 Feb; 162():20-27.e1. PubMed ID: 26596399
[TBL] [Abstract][Full Text] [Related]
24. New concepts in the molecular understanding of uveal melanoma.
Reichstein D
Curr Opin Ophthalmol; 2017 May; 28(3):219-227. PubMed ID: 28257297
[TBL] [Abstract][Full Text] [Related]
25. Validation of the Prognostic Usefulness of the Gene Expression Profiling Test in Patients with Uveal Melanoma.
Miguez S; Lee RY; Chan AX; Demkowicz PC; Jones BSCL; Long CP; Abramson DH; Bosenberg M; Sznol M; Kluger H; Goldbaum MH; Francis JH; Pointdujour-Lim R; Bakhoum MF
Ophthalmology; 2023 Jun; 130(6):598-607. PubMed ID: 36739981
[TBL] [Abstract][Full Text] [Related]
26. Intrinsic disorder in PRAME and its role in uveal melanoma.
Antonietti M; Gonzalez DJT; Djulbegovic M; Dayhoff GW; Uversky VN; Shields CL; Karp CL
Cell Commun Signal; 2023 Aug; 21(1):222. PubMed ID: 37626310
[TBL] [Abstract][Full Text] [Related]
27. Yield, Techniques, and Complications of Transvitreal and Transscleral Biopsies in Small Uveal Melanoma.
Kim RS; Chevez-Barrios P; Divatia M; Bretana ME; Teh B; Schefler AC
JAMA Ophthalmol; 2018 May; 136(5):482-488. PubMed ID: 29596552
[TBL] [Abstract][Full Text] [Related]
28. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
Yang B; Gu A; Wu Y
Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic utility of immunohistochemistry in concordance with mRNA analysis of PRAME in the stratification of high-risk uveal melanoma patients.
Kumar N; Singh MK; Singh L; Lomi N; Meel R; Pushker N; Sen S; Kashyap S
Hum Cell; 2023 Jan; 36(1):342-352. PubMed ID: 36282437
[TBL] [Abstract][Full Text] [Related]
30. iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors.
Crabb JW; Hu B; Crabb JS; Triozzi P; Saunthararajah Y; Tubbs R; Singh AD
PLoS One; 2015; 10(8):e0135543. PubMed ID: 26305875
[TBL] [Abstract][Full Text] [Related]
31. Proteomic analysis of vitreous biopsy techniques.
Skeie JM; Brown EN; Martinez HD; Russell SR; Birkholz ES; Folk JC; Boldt HC; Gehrs KM; Stone EM; Wright ME; Mahajan VB
Retina; 2012; 32(10):2141-9. PubMed ID: 23095728
[TBL] [Abstract][Full Text] [Related]
32. The Potential Role of Selected miRNA in Uveal Melanoma Primary Tumors as Early Biomarkers of Disease Progression.
Wróblewska JP; Lach MS; Ustaszewski A; Kulcenty K; Ibbs M; Jagiełło I; Suchorska WM; Marszałek A
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32131485
[TBL] [Abstract][Full Text] [Related]
33. Proteomic analysis of autoimmune retinopathy implicates NrCAM as a potential biomarker.
Al-Moujahed A; Velez G; Vu JT; Lima de Carvalho JR; Levi SR; Bassuk AG; Sepah YJ; Tsang SH; Mahajan VB
Ophthalmol Sci; 2022 Jun; 2(2):. PubMed ID: 35529077
[TBL] [Abstract][Full Text] [Related]
34. Potential of Aqueous Humor as a Liquid Biopsy for Uveal Melanoma.
Im DH; Peng CC; Xu L; Kim ME; Ostrow D; Yellapantula V; Bootwalla M; Biegel JA; Gai X; Prabakar RK; Kuhn P; Hicks J; Berry JL
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682905
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Implications of Tumor Diameter in Association With Gene Expression Profile for Uveal Melanoma.
Walter SD; Chao DL; Feuer W; Schiffman J; Char DH; Harbour JW
JAMA Ophthalmol; 2016 Jul; 134(7):734-40. PubMed ID: 27123792
[TBL] [Abstract][Full Text] [Related]
36. Multiple Genetically Distinct Uveal Melanomas Arise in the Same Eye of Two Patients with Melanosis Oculi.
Wagley S; Belin PJ; Dollar JJ; Harbour JW; Maltry AC; Mruthyunjaya P; Schefler AC; Tang PH
Am J Ophthalmol; 2022 Feb; 234():1-5. PubMed ID: 34283976
[TBL] [Abstract][Full Text] [Related]
37. OSuvm: An interactive online consensus survival tool for uveal melanoma prognosis analysis.
Wang F; Wang Q; Li N; Ge L; Yang M; An Y; Zhang G; Dong H; Ji S; Zhu W; Guo X
Mol Carcinog; 2020 Jan; 59(1):56-61. PubMed ID: 31646691
[TBL] [Abstract][Full Text] [Related]
38. Prognostic impact of HERC2 protein and pink-eyed dilution protein in uveal melanoma.
Kashyap S; Singh MK; Jha J; Singh L; Pushker N; Sen S; Venkatesh P; Meel R; Lomi N
Hum Cell; 2020 Oct; 33(4):1264-1272. PubMed ID: 32686068
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristics.
Plasseraud KM; Wilkinson JK; Oelschlager KM; Poteet TM; Cook RW; Stone JF; Monzon FA
Diagn Pathol; 2017 Aug; 12(1):59. PubMed ID: 28778171
[TBL] [Abstract][Full Text] [Related]
40. N
Wang T; Bai J; Zhang Y; Xue Y; Peng Q
Front Immunol; 2022; 13():918522. PubMed ID: 36003405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
